AMENDMENT N°5 TO THE A350 FAMILY PURCHASE AGREEMENT BETWEEN AIRBUS S.A.S. as Seller and AIR LEASE CORPORATION As Buyer

EX-10.16 9 al-20160630ex10165fe63.htm EX-10.16 al_Ex10_16

EXHIBIT 10.16

 

Confidential Treatment
Requested Pursuant to Rule 24b-2

 

 

AMENDMENT N°5

 

 

TO THE

 

 

 

A350 FAMILY PURCHASE AGREEMENT

 

 

 

BETWEEN

 

 

 

AIRBUS S.A.S.

 

as Seller

 

 

 

and

 

 

 

AIR LEASE CORPORATION

 

As Buyer

Page 1/5


 

AMENDMENT N°5 TO THE

A350 FAMILY PURCHASE AGREEMENT

 

 

This amendment N°5 (the “Amendment N°5) dated 25 May 2016 is made

 

BETWEEN:

 

AIRBUS S.A.S., a  société par actions simplifiée, created and existing under French law having its registered office at 1 Rond‑Point Maurice Bellonte, 31707 Blagnac-Cedex, France and registered with the Toulouse Registre du Commerce under number RCS Toulouse 383 474 814 (the "Seller"),

 

and

 

AIR LEASE CORPORATION, a corporation organised and existing under the laws of the State of Delaware, U.S.A., having its principal place of business at 2000 Avenue of the Stars, Suite 1000N, Los Angeles, California 90067, U.S.A. (the “Buyer”).

 

The Buyer and Seller together are referred to as the “Parties”.

 

WHEREAS:

 

A.   The Buyer and the Seller have signed a purchase agreement with reference CLC-CT1103521 on the 1st February 2013 for the manufacture and sale by the Seller and purchase by the Buyer of twenty-five (25) firm A350 Family aircraft hereinafter together with its Exhibits and Letter Agreements referred to as the “Purchase Agreement”.

 

B.   On 3rd March 2015, the Buyer and the Seller entered into an Amendment N°1 to the Purchase Agreement to modify the terms and conditions with respect to certain A350XWB Family Aircraft.

 

C.   On 3rd March 2015, the Buyer and the Seller entered into an Amendment N°2 to the Purchase Agreement for the manufacture and sale by the Seller and purchase by the Buyer of one (1) incremental A350-900 Aircraft.

 

D.   On 08th September 2015, the Buyer and the Seller entered into an Amendment N°3 to the Purchase Agreement for (i) the manufacture and sale by the Seller and purchase by the Buyer of two (2) incremental A350-900 Aircraft and (ii) [*].

 

E.   On 14th April 2016, the Buyer and the Seller entered into an Amendment N°4 to the Purchase Agreement for (i) the manufacture and sale by the Seller and purchase by the Buyer of one (1) incremental A350-900 Aircraft and (ii) [*].

 

The Purchase Agreement as amended and supplemented pursuant to the foregoing shall be referred to as the “Agreement”.

 

F.   The Buyer and the Seller now wish to enter into this Amendment N°5 in order to [*].

 

The terms “herein”, “hereof” and “hereunder” and words of similar import refer to this Amendment N°5. Capitalized terms used herein and not otherwise defined herein shall have the meanings assigned thereto in the Agreement.

 


* Confidential material omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.

Page 2/5


 

NOW IT IS HEREBY AGREED AS FOLLOWS:

 

1.                  [*]

 

1.1               The Seller hereby agrees to [*].  

 

1.2               The table in Clause 9.1.1 of the Purchase Agreement, as may have been amended from time to time, is hereby deleted in its entirety and replaced by the one set forth in Appendix 1 hereto.

 

1.3                [*]

 

 

2.                 [*]

 

[*]

 

3.                 INCONSISTENCY AND CONFIDENTIALITY

 

3.1               In the event of any inconsistency between the terms and conditions of the Agreement and those of this Amendment N°5, the latter shall prevail to the extent of such inconsistency, whereas the part of the Agreement not concerned by such inconsistency shall remain in full force and effect.

 

3.2               This Amendment N°5 reflects the understandings, commitments, agreements, representations and negotiations related to the matters set forth herein whatsoever, oral and written, and may not be varied except by an instrument in writing of even date herewith or subsequent hereto executed by the duly authorised representatives of both Parties.

 

3.3               This Amendment N°5 shall be treated by both Parties as confidential and shall not be released in whole or in part to any third party without the prior consent of the other Party except as may be required by law, or to professional advisors for the implementation hereof.

 

4.                 COUNTERPARTS

 

This Amendment N°5 may be executed by the Parties in separate counterparts, each of which when so executed and delivered shall be an original, but all such counterparts shall together constitute one and the same instrument.

 

5.                 LAW AND JURISDICTION

 

The provisions of Clause 22.6 of the Purchase Agreement shall apply to this Amendment N°5 as if the same were set out in full herein, mutatis mutandis.

 


* Confidential material omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.

Page 3/5


 

IN WITNESS WHEREOF this Amendment N°5 was entered into the day and year first above written.

 

 

For and on behalf of

    

For and on behalf of

 

 

 

 

 

 

 

 

 

AIR LEASE CORPORATION

 

AIRBUS S.A.S.

 

 

 

 

 

 

 

 

 

By:

/s/ Grant Levy

 

By:

/s/ Christophe Mourey

 

 

 

 

 

Its:

Executive Vice President

 

Its:

Senior Vice President Contracts

 

Page 4/5


 

 

Aircraft

CAC ID

Scheduled Delivery
Month

Aircraft
Type

[*]

[*]

[*]

2017

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

[*]

2024

[*]

 


Confidential material omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.

Page 5/5